These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1247716)

  • 1. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic lidocaine in suspected acute myocardial infarction.
    Goodman SL; Geiderman JM; Bernstein IJ
    JACEP; 1979 Jun; 8(6):221-4. PubMed ID: 449144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
    Prescott LF; Adjepon-Yamoah KK; Talbot RG
    Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of ventricular dysrhythmias following acute myocardial infarction: a double-blind trial of continuous intravenous infusion of lignocaine.
    Baker IA; Collins JV; Evans TR
    Guys Hosp Rep; 1971; 120(1):1-7. PubMed ID: 4934490
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lignocaine: a new technique for intravenous administration.
    Levy RA; Charuzi Y; Mandel WJ
    Br Heart J; 1977 Sep; 39(9):1026-8. PubMed ID: 907767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration.
    Sheridan DJ; Crawford L; Rawlins MD; Julian DG
    Lancet; 1977 Apr; 1(8016):824-5. PubMed ID: 67335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple lignocaine regimen for transit to hospital after myocardial infarction.
    Barber JM; Boyle DM; Hussain Z; McDevitt DG
    Br Heart J; 1977 Dec; 39(12):1361-3. PubMed ID: 603738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds GW; Hafizullah M; Kalra PA; Jackson NC; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):707-14. PubMed ID: 3105568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
    Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
    Chopra MP; Thadani U; Portal RW; Aber CP
    Br Med J; 1971 Sep; 3(5776):668-70. PubMed ID: 4936439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.